Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model

Mutation Research - DNA Repair

Volumn 408, Issue 1, 1998, Pages 27-35

  Tomkins, Darrell J ^a,b   Care, Melanie ^a   Carreau, Madeleine ^c   Buchwald, Manuel ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c NONE

Author keywords

Chromosomal aberration; Cross linking agent; Cytotoxicity; Fanconi anemia; Mouse model

Indexed keywords

BUTADIENE DIEPOXIDE; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW DEPRESSION; CELL IMMORTALIZATION; CELL KILLING; CELL MATURATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CONTROLLED STUDY; CROSS LINKING; CYTOGENETICS; FANCONI ANEMIA; FIBROBLAST; GENE MUTATION; GENETIC PREDISPOSITION; LYMPHOBLASTOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CHROMOSOME ABERRATIONS; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FIBROBLASTS; MICE; MICE, KNOCKOUT; MITOMYCIN; MUTAGENICITY TESTS; NUCLEAR PROTEINS; PHENOTYPE; PROTEINS; TOXICITY TESTS;

ANIMALIA;

EID: 0032127660     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(98)00015-9     Document Type: Article

References (32)

1. [1] A. S. Levine, Workshop on molecular, cellular, and clinical aspects of Fanconi anemia, Exp. Hematol. 21 (1993) 703-726.
2. [2] A.D. Auerbach, Fanconi anemia, Dermatol. Clin. 13 (1995) 41-49.
3. [3] R. Weksberg, M. Buchwald, P. Sargent, M.W. Thompson, L. Siminovitch, Specific cellular defects in patients with Fanconi anemia, J. Cell. Physiol. 101 (1979) 311-324.
4. [4] B. Dutrillaux, A. Aurias, A.-M. Dutrillaux, D. Buriot, M. Prieur, The cell cycle of lymphocytes in Fanconi anemia, Hum. Genet. 62 (1982) 327-332.
5. [5] M. Kubbies, D. Schindler, H. Hoehn, A. Schinzel, P.S. Rabinovitch, Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase, Am. J. Hum. Genet. 37 (1985) 1022-1030.
6. [6] C.A. Strathdee, A.M.V. Duncan, M. Buchwald, Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9, Nat. Genet. 1 (1992) 196-198.
7. [7] H. Joenje, A.B. Oostra, M. Wijker, F.M. di Summa, C.G.M. van Berkel, M.A. Rooimans, W. Ebell, M. van Weel, J.C. Pronk, M. Buchwald, F. Arwert, Evidence for at least eight Fanconi anemia genes, Am. J. Hum. Genet. 61 (1997) 940-944.
8. [8] M. Buchwald, Complementation groups: one or more per gene?, Nat. Genet. 11 (1995) 228-230.
9. [9] C.A. Strathdee, H. Gavish, W.R. Shannon, M. Buchwald, Cloning of cDNAs for Fanconi's anaemia by functional complementation, Nature 356 (1992) 763-767.
10. [10] D.J. Stavropoulos, S. Sood, D.J. Tomkins, M. Buchwald, Correction of the spontaneous and DEB-induced chromosomal aberrations in Fanconi anemia cells of the FA(C) complementation group by the FACC gene, Cytogenet. Cell Genet. 72 (1996) 194-196.
11. [11] H. Gavish, C.A. Clarke, W.R. Shannon, M. Buchwald, The Fanconi anemia (FACC) protein is primarily localized in the nucleus, Am. J. Hum. Genet. 53 (Suppl. 3) (1993) 685, [abstract].
12. [12] W. Liebetrau, M. Bühner, H. Hoehn, Prototype sequence clues within the Fanconi anaemia group C gene, J. Med. Genet. 32 (1995) 669-670.
13. [13] H. Youssoufian, Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7975-7979.
14. [14] H. Youssoufian, A.D. Auerbach, P.C. Verlander, V. Steimle, B. Mach, Identification of cytosolic proteins that bind to the Fanconi anemia complementation group C polypeptide in vitro, J. Biol. Chem. 270 (1995) 9876-9882.
15. [15] G.M. Kupfer, D. Näf, A. Suliman, M. Pulsipher, A.D. D' Andrea, The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex, Nat. Genet. 17 (1997) 487-490.
16. [16] P.M. Jakobs, P. Sahaayaruban, H. Saito, C. Reifsteck, S. Olson, H. Joenje, R.E. Moses, M. Grompe, Immortalization of four new Fanconi anemia fibroblast cell lines by an improved procedure, Somatic Cell Mol. Genet. 22 (1996) 151-157.
17. [17] R. Wevrick, C.A. Clarke, M. Buchwald, Cloning and analysis of the murine Fanconi anemia group C cDNA, Hum. Mol. Genet. 2 (1993) 655-662.
18. [18] M. Chen, D.J. Tomkins, W. Auerbach, C. McKerlie, H. Youssoufian, L. Liu, O. Gan, M. Carreau, A. Auerbach, T. Groves, C.J. Guidos, M.H. Freedman, J. Cross, D.H. Dercy, J.E. Dick, A.L. Joyner, M. Buchwald, Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anemia, Nat. Genet. 12 (1996) 448-451.
19. [19] G. Duckworth-Rysiecki, L. Toji, J. Ng, C. Clarke, M. Buchwald, Characterization of a Simian virus 40-transformed Fanconi anemia fibroblast cell line, Mutation Res. 166 (1986) 207-214.
20. [20] L. Daya-Grosjean, M.R. James, C. Drougard, A. Sarasin, An immortalized xeroderma pigmentosum, group C, cell line which replicates SV40 shuttle vectors, Mutat. Res. 183 (1987) 185-196.
21. [21] A.D. Bloom (Ed.), Guidelines for Studies of Human Populations Exposed to Mutagenic and Reproductive Hazards, March of Dimes Birth Defects Foundation, White Plains, NY, 1981, pp. 11-16.
22. [22] R. Finkelberg, M.W. Thompson, L. Siminovitch, Survival after treatment with EMS, γ-rays and mitomycin C of skin fibroblasts from patients with Fanconi's anemia, Am. J. Hum. Genet. 26 (1974) 301A, [abstract].
23. [23] M.S. Sasaki, Fanconi's anemia, a condition possibly associated with a defective DNA repair, in: P.C. Hanawalt, E.G. Friedberg, C.F. Fox (Eds.), DNA Repair Mechanisms, Academic Press, New York, 1978, pp. 675-684.
24. [24] R. Ishida, M. Buchwald, Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents, Cancer Res. 42 (1982) 4000-4006.
25. [25] A.D. Auerbach, B. Adler, R.S.K. Chaganti, Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method, Pediatrics 67 (1981) 128-135.
26. [26] J. Cervenka, D. Arthur, C. Yasis, Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia, Pediatrics 67 (1981) 119-127.
27. [27] A.D. Auerbach, S.R. Wolman, Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens, Nature 261 (1976) 494-496.
28. [28] S.A. Latt, G. Stellen, L.A. Juergens, G.R. Buchanan, P.S. Gerald, Induction by alkylaling agents of sister chromalid exchanges and chromalid breaks in Fanconi's anemia, Proc. Natl. Acad. Sci. U.S.A. 72 (1975) 4066-4070.
29. [29] C.E. Walsh, A.W. Nienhuis, R.J. Samulksi, M.G. Brown, J.L. Miller, N.S. Young, J.M. Liu, Phenotypic correction of Fanconi anemia in human hematopoietic cells wilh a recombinant adeno-associated virus vector, J. Clin. Invest 94 (1994) 1440-1448.
30. [30] B. Dallapiccola, B. Porfiro, Chromosomal studies in Fanconi anemia heterozygotes, in: T.M. Schroeder-Kurth, A.D. Auerbach (Eds.), Fanconi Anemia, Clinical, Cytogenetic and Experimental Aspects, Springer-Verlag, Berlin, 1989, pp. 145-158.
31. [31] J. Rosendorff, R. Bernstein, Fanconi's anemia - chromosome breakage studies in homozygotes and heterozygotes, Cancer Genet. Cytogenet. 33 (1988) 175-183.
32. [32] T.M. Schroeder, F. Anschütz, A. Knopp, Spontane chromosomenaberrationen bei familiärer panmyelopathie, Humangenetik 1 (1964) 194-196.